Alzheimer’s disease is a devastating neurodegenerative disorder and the most common form of dementia. It’s marked by the ...

Brain and the nervous system may remain altered for months without producing obvious Alzheimer’s-like behaviour ...

Scientists identified a potential early indicator of cognitive decline, pointing to an avenue for new research.

MRI scans can detect signs of the disease years earlier than PET scans, a recent study published in ‘Nature Neuroscience’ ...

The finding in human cerebrospinal fluid also raises the possibility of using meprin-β as an indicator of Alzheimer’s. This ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

Cure Alzheimer’s Fund® (CureAlz®) today announced its second cohort of Cardinal Family Scholars who, combined, will receive a total of $6.4 mi ...

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

"If we can slow down aging in the brain for those people most at risk, maybe we can reduce the risk of them developing ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.